Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse

NCT06827860 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma in Relapse

Interventions

DRUG: Talquetamab
DRUG: Daratumumab

Sponsor

Larysa Sanchez

Collaborators

[object Object]